logo
  

Quest Diagnostics To Acquire Laboratory Services Business Of BBPL - Quick Facts

Quest Diagnostics Inc. (DGX), a provider of diagnostic information services, said Tuesday that it agreed to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories or BBPL, a provider of diagnostic and clinical laboratory services in the Midwest. Financial terms of the transaction were not disclosed.

BBPL's anatomic pathology division, Boyce and Bynum Pathology Professional Services, Inc. or BBPPS, and long-term care division are not part of the transaction, Quest said.

Quest noted that through a separate professional services agreement, BBPPS will become the exclusive pathology provider for Quest Diagnostics' clients in Missouri and a preferred pathology provider in the greater Midwestern region.

The professional services agreement will go into effect at the time the acquisition is completed, which is expected in the first quarter of 2019.

According to Quest, the relationship between BBPL and the company will result in a broader menu of clinical laboratory and anatomic pathology services throughout the region. The relationship will also give patients access to an expanded network of service centers across the Midwest, for greater convenience.

"This relationship will extend our ability to provide the most innovative, cost-efficient services to patients and providers in the nation's heartland, deepening our presence in the region. It is consistent with our accelerate growth strategy, which includes delivering one to two percent in annual revenue through strategically aligned accretive acquisitions," said Steve Rusckowski, Chairman, President and CEO of Quest Diagnostics.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Boeing expects Europe's commercial aviation fleet to need 8,705 new airplanes through 2040 to cater to the growing leisure travel market in the region and fleet replacements with more fuel-efficient models, according to the Boeing's 2021 Commercial Market Outlook (CMO), an annual forecast of long-term demand for commercial airplanes and services. The U.S. Food and Drug Administration authorized marketing of a software developed by Paige.AI, a provider of AI-based digital diagnostics, which could help pathologists to identify prostate cancer. The software, called Paige Prostate, is the first and only artificial intelligence or AI-based pathology product to receive FDA approval for in vitro diagnostic or IVD use in detecting cancer... General Mills (GIS) said its first-quarter top- and bottom-line results were ahead of its expectations. The company also reaffirmed its fiscal 2022 outlook. Looking forward, General Mills anticipates changes in consumer behaviors driven by the COVID-19 pandemic will result in ongoing elevated consumer...
Follow RTT